2012
DOI: 10.2223/jped.2204
|View full text |Cite
|
Sign up to set email alerts
|

Alternating antipyretics in the treatment of fever in children: a systematic review of randomized clinical trials

Abstract: Objective: To summarize the existing evidence on the efficacy of therapy with alternating antipyretics compared to monotherapy in the management of fever in children.Sources: MEDLINE, EMBASE, Cochrane Library, LILACS, SciELO, IBECS, Web of Science, Clinical Trials, Google Scholar and references of the articles found. The review included randomized clinical trials published until December 2011, in which one of the arms was the alternating antipyretics therapy to treat fever in children younger than 12 years, tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0
4

Year Published

2013
2013
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(13 citation statements)
references
References 40 publications
0
9
0
4
Order By: Relevance
“…[2,[8][9][10][11][12][13][14] (Evidence A) • The practices of combining or alternating paracetamol and ibuprofen have limited value and are not recommended. [15,16] (Evidence B) • Mefenamic acid is registered for use from 6 months of age and may be an alternative non-steroidal anti-inflammatory (NSAID) to ibuprofen in children with fever. The recommended dose is 6.5 mg/kg of body weight, not more than three times daily (Evidence B).…”
Section: Antipyretic Medicationmentioning
confidence: 99%
“…[2,[8][9][10][11][12][13][14] (Evidence A) • The practices of combining or alternating paracetamol and ibuprofen have limited value and are not recommended. [15,16] (Evidence B) • Mefenamic acid is registered for use from 6 months of age and may be an alternative non-steroidal anti-inflammatory (NSAID) to ibuprofen in children with fever. The recommended dose is 6.5 mg/kg of body weight, not more than three times daily (Evidence B).…”
Section: Antipyretic Medicationmentioning
confidence: 99%
“…O risco de ocorrência de agranulocitose e anemia aplásica, relacionadas à dipirona, é uma questão amplamente discutida e pouco esclarecida (15) . O paracetamol é derivado do aminofenol, prescrito na dose de 10 a 15 mg/Kg, apresenta biotransformação hepática e risco de hepatotoxicidade, seu uso em crianças com menos de 2 anos de idade ou menos de 11 Kg requer orientação médica (16) . Neste estudo, embora ocorra baixa incidência de automedicação com ácido acetilsalicílico (AAS), esse AINE, utilizado principalmente como paliativo nos sintomas das doenças envolvendo vias respiratórias superiores, está estreitamente relacionado ao risco de Síndrome de Reye (4)(5)8,(15)(16) .…”
Section: Resultsunclassified
“…2,[5][6][7][8][9][10][11] The practice of combining or alternating paracetamol and ibuprofen has limited value and is not recommended. [12][13][14] Mefenamic acid is registered for use from six months of age, and may be an alternative nonsteroidal anti-inflammatory drug (NSAID) to ibuprofen in children with fever. The recommended dose is 6.5 mg/kg body weight, not more than three times daily.…”
Section: Antipyretic Medicationmentioning
confidence: 99%